跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 98,420 条关于
“GBA1-driven Parkinson's Disease”
全部
98,420
临床试验
72,041
药物
2,087
机构
221
资讯
24,071
6个月前
Congruence Therapeutics and Ono Pharmaceutical Expand Partnership to Target Neurology and Immunology Programs
7个月前
Bial's Phase 2b ACTIVATE Study Reaches 75% Completion Milestone for GBA1-Associated Parkinson's Disease Treatment
3个月前
Bial Completes Phase 2b ACTIVATE Study of Potential First-in-Class GBA1 Parkinson's Treatment
去年
BIAL's BIA 28-6156 Phase 2 Trial Reaches Milestone with First Patient Completion
3年前
BIAL Doses First Patient in Phase 2 Trial of BIA 28-6156 for GBA-Related Parkinson's Disease
3年前
BIAL R&D Doses First Patient in Phase 2 Trial of BIA 28-6156 for Parkinson's Disease with GBA1 Mutation
2年前
Gain Therapeutics' GT-02287 Shows Promise in Phase 1 Trial for Parkinson's Disease
11个月前
Bial's BIA 28-6156 Reaches Key Milestone in Phase 2 Trial for GBA-Associated Parkinson's Disease
去年
Gain Therapeutics' GT-02287 Enters Phase 1b Trial for Parkinson's Disease
去年
Neuron23 Advances Precision Medicine in Parkinson's Disease with Digital Biomarker-Driven Phase 2 Trial
第 1 页，共 2408 页
上一页
下一页
